Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1149361

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's policies of the matters raised in the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	402
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149365

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if the NHS will allocate additional funding to NHS trusts to cover increased costs incurred for the supply of medical isotopes in the event that the UK leaves the EU without a deal.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	403
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake

1149367

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if his Department will respond to the concerns raised in that letter about the timely delivery of medical radioisotopes to the North of England, the South West of England, Wales, Scotland and Northern Ireland.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	405
answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 403 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
tabling member	151 label Biography information for Tom Brake